摘要 |
FIELD: medicine. SUBSTANCE: present invention describes biologically active compounds, more particularly arylaliphatic aminoazides of general formula I: <EMI ID=0.679 HE=12 WI=42 TI=CHI> wherein when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>5</SB>,, then R<SB>1</SB> is NC<SB>4</SB>H<SB>8</SB>O, and n is 4,5, 6 and 7; R<SB>1</SB> is NC<SB>5</SB>H<SB>10</SB>,, and n is 4,5,6 and 7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>4</SB>CH<SB>3</SB>-4, then R<SB>1</SB> is N(CH<SB>3</SB>)<SB>2</SB>,, and n is 4,5,6 and 7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>4</SB>CH<SB>3</SB>-2,, then R<SB>1</SB> is NC<SB>5</SB>H<SB>10</SB>, and n is 4,5,6 and 7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>4</SB>OCH<SB>3</SB>-2, then R<SB>1</SB> is N(CH<SB>3</SB>)<SB>2</SB>, and n is 4,5,6 and 7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>4</SB>NO<SB>2</SB>-4, then R<SB>1</SB> is N(C<SB>2</SB>H<SB>5</SB>)<SB>2</SB>, and n is 4,5,6,7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>4</SB>F-4, then R<SB>1</SB> is NC<SB>5</SB>H<SB>10</SB>, and n is 4,5,6,7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>4</SB>Br-4, then R<SB>1</SB> is N(CH<SB>3</SB>)<SB>2</SB>,, and n is 4,5,6,7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>4</SB>Cl-2, then R<SB>1</SB> is NC<SB>5</SB>H<SB>10</SB>, and n is 4,5,6 and 7; R<SB>1</SB> is N(CH<SB>3</SB>)<SB>2</SB> and n is 4,5,6 and 7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>4</SB>Cl-3, then R<SB>1</SB> is NC<SB>4</SB>H<SB>8</SB>O, and n is 4,5,6 and 7; when R<SB>1</SB> is N(CH<SB>3</SB>)<SB>2</SB> and n is 4,5,6 and 7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>4</SB>Cl-4, then R<SB>1/ </SB> is NC<SB>4</SB>H<SB>8</SB>O, and n is 4,5,6 and 7; when R<SB>1</SB> is NC<SB>5</SB>H<SB>10</SB>, and n is 4,5,6,7; when R is CH<SB>2</SB>OC<SB>6</SB>H<SB>3</SB>Cl<SB>2</SB>-2,4, then R<SB>1</SB> is N(CH<SB>3</SB>)<SB>2</SB>, and n is 4,5,6 and 7; when R<SB>1</SB> is NC<SB>5</SB>H<SB>10</SB>, and n is 4,5,6 and 7; when R<SB>1</SB> is N(C<SB>2</SB>H<SB>5</SB>)<SB>2</SB>, and n is 4,5,6,7; when R<SB>1</SB> is NC<SB>4</SB>H<SB>8</SB>O and n is 4,5,6,7; when R is CH<SB>2</SB
|